Gene expression of inflammatory mediators implicated in AKI such as CXCL-1, CXCL-2, IL-1β, IL-6, TNF-α and RANTES were not significantly altered by Pepstatin A treatment (Fig. 5B,C and Suppl. The gene discussed is CCL5; the disease is acute kidney injury.